Association of First-Trimester Pan-Immune-Inflammation Value with Chronic Histiocytic Intervillositis and Villitis of Unknown Etiology
- 21 July 2026
- journal article
- research article
- Published by SAGE Publications in Pediatric and Developmental Pathology
Abstract
Background: Chronic histiocytic intervillositis (CHI) and villitis of unknown etiology (VUE) are immune-mediated placental disorders leading to adverse pregnancy outcomes. This study investigated whether first-trimester pan-immune-inflammation value (PIV), a novel systemic inflammation marker, is associated with these conditions. Methods: This retrospective case-control study (October 2022-August 2025) included 163 placentas (25 controls, 63 CHI, 75 VUE). First-trimester complete blood counts (P = .048). Across groups, PIV was highest in CHI (661.6), intermediate in VUE (446.4), and lowest in controls ( P < .001). CHI showed the worst perinatal outcomes: lowest gestational age (30.5 weeks), birth weight, and Apgar scores, and highest intrauterine fetal death (41.3%). After multivariable adjustment, first-trimester PIV remained independently associated with CHI (aOR 1.87, 95% CI 1.19-4.27, P = .005) but not with VUE (aOR 0.74, P = 0.103). Discriminatory performance was modest for CHI (AUC 0.677) and poor for VUE (AUC 0.434). Conclusion: Elevated first-trimester PIV is independently associated with CHI but not VUE, suggesting that systemic maternal inflammation may be detectable early in gestation, particularly in more severe placental immune pathology. PIV is not a standalone diagnostic test but may contribute to risk assessment when combined with clinical findings.Keywords
This publication has 14 references indexed in Scilit:
- Immune tolerance breakdown in pregnancy: transplantation parallels in chronic intervillositis and villitis of unknown etiologyAmerican Journal of Obstetrics and Gynecology, 2025
- Histologic and molecular features shared between antibody‐mediated rejection of kidney allografts and chronic histiocytic intervillositis support common pathogenesisThe Journal of Pathology, 2025
- Spatial proteomics reveals phenotypic and functional differences in T cell and macrophage subsets during villitis of unknown etiologyScientific Reports, 2024
- Villitis of unknown etiology, chronic deciduitis, chronic chorioamnionitis and chronic histiocytic intervillositis in monozygotic and dizygotic twin pregnancies. A retrospective analysis of 16 casesPlacenta, 2023
- Chronic histiocytic intervillositis: manifestation of placental alloantibody-mediated rejectionAmerican Journal of Obstetrics and Gynecology, 2021
- Chronic histiocytic intervillositis: A breakdown in immune tolerance comparable to allograft rejection?American Journal of Reproductive Immunology, 2020
- Towards standardized criteria for diagnosing chronic intervillositis of unknown etiology: A systematic reviewPlacenta, 2018
- Placental pathologic lesions with a significant recurrence risk – what not to miss!APMIS, 2017
- Characterizing Villitis of Unknown Etiology and Inflammation in StillbirthThe American Journal of Pathology, 2016
- Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significanceAmerican Journal of Obstetrics and Gynecology, 2015